In vitro study of histamine and histamine receptor ligands influence on the adhesion of purified human eosinophils to endothelium.

[1]  J. Schwartz,et al.  Pitolisant versus placebo or modafinil in patients with narcolepsy: a double-blind, randomised trial , 2013, The Lancet Neurology.

[2]  R. Seifert.  Functional selectivity of G-protein-coupled receptors: from recombinant systems to native human cells. , 2013, Biochemical pharmacology.

[3]  R. Leurs,et al.  Detailed analysis of biased histamine H4 receptor signalling by JNJ 7777120 analogues , 2013, British journal of pharmacology.

[4]  K. Karlstedt,et al.  Expression of histamine receptor genes Hrh3 and Hrh4 in rat brain endothelial cells , 2013, British journal of pharmacology.

[5]  R. Thurmond,et al.  Antagonism of the histamine H4 receptor reduces LPS-induced TNF production in vivo , 2013, Inflammation Research.

[6]  Hemant R. Jadhav,et al.  Histamine H3 receptor function and ligands: recent developments. , 2012, Mini reviews in medicinal chemistry.

[7]  K. Dyer,et al.  Eosinophils: changing perspectives in health and disease , 2012, Nature Reviews Immunology.

[8]  R. Seifert,et al.  Incomplete activation of human eosinophils via the histamine H4-receptor: evidence for ligand-specific receptor conformations. , 2012, Biochemical pharmacology.

[9]  E. Tiligada.  Editorial: Is histamine the missing link in chronic inflammation? , 2012, Journal of leukocyte biology.

[10]  H. Kita.  Eosinophils: multifaceted biological properties and roles in health and disease , 2011, Immunological reviews.

[11]  A. Strasser,et al.  Paradoxical Stimulatory Effects of the “Standard” Histamine H4-Receptor Antagonist JNJ7777120: the H4 Receptor Joins the Club of 7 Transmembrane Domain Receptors Exhibiting Functional Selectivity , 2011, Molecular Pharmacology.

[12]  K. Dyer,et al.  Isolation of human eosinophils: microbead method has no impact on IL‐5 sustained viability , 2010, Experimental dermatology.

[13]  E. Tiligada,et al.  The role of histamine H4 receptor in immune and inflammatory disorders , 2009, British journal of pharmacology.

[14]  Rob Leurs,et al.  Molecular and biochemical pharmacology of the histamine H4 receptor , 2009, British journal of pharmacology.

[15]  A. Mahdy,et al.  Histamine and antihistamines , 2008 .

[16]  M. Cybulsky,et al.  Getting to the site of inflammation: the leukocyte adhesion cascade updated , 2007, Nature Reviews Immunology.

[17]  Rob Leurs,et al.  Evaluation of Histamine H1-, H2-, and H3-Receptor Ligands at the Human Histamine H4 Receptor: Identification of 4-Methylhistamine as the First Potent and Selective H4 Receptor Agonist , 2005, Journal of Pharmacology and Experimental Therapeutics.

[18]  E. Moilanen,et al.  Pharmacological regulation of human eosinophil apoptosis. , 2005, Current drug targets. Inflammation and allergy.

[19]  R. Thurmond,et al.  Histamine H4 receptor mediates eosinophil chemotaxis with cell shape change and adhesion molecule upregulation , 2004, British journal of pharmacology.

[20]  T. Williams,et al.  Histamine induces cytoskeletal changes in human eosinophils via the H4 receptor , 2003, British journal of pharmacology.

[21]  J. A. Jablonowski,et al.  The first potent and selective non-imidazole human histamine H4 receptor antagonists. , 2003, Journal of medicinal chemistry.

[22]  R. Leurs,et al.  Histamine H(1)-receptor activation of nuclear factor-kappa B: roles for G beta gamma- and G alpha(q/11)-subunits in constitutive and agonist-mediated signaling. , 2001, Molecular pharmacology.

[23]  Nicholas J. Carruthers,et al.  Cloning and pharmacological characterization of a fourth histamine receptor (H(4)) expressed in bone marrow. , 2001, Molecular pharmacology.

[24]  C. Ezeamuzie,et al.  Histamine H2 receptors mediate the inhibitory effect of histamine on human eosinophil degranulation , 2000, British journal of pharmacology.

[25]  P. Hellewell,et al.  A CD18/ICAM-1-dependent pathway mediates eosinophil adhesion to human bronchial epithelial cells. , 1998, American journal of respiratory cell and molecular biology.

[26]  H. Haas,et al.  International Union of Pharmacology. XIII. Classification of histamine receptors. , 1997, Pharmacological reviews.

[27]  N. Krug,et al.  Identification of eosinophils by flow cytometry. , 1996, Cytometry.

[28]  E. Schulman,et al.  Pharmacologic characterization of a novel histamine receptor on human eosinophils. , 1994, American journal of respiratory and critical care medicine.

[29]  K. Blaser,et al.  An improved immunomagnetic procedure for the isolation of highly purified human blood eosinophils. , 1991, Journal of immunological methods.

[30]  J. G. Cory,et al.  Use of an aqueous soluble tetrazolium/formazan assay for cell growth assays in culture. , 1991, Cancer communications.

[31]  C. Edgell,et al.  Permanent cell line expressing human factor VIII-related antigen established by hybridization. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[32]  S. Pincus,et al.  Superoxide production by eosinophils: activation by histamine. , 1982, The Journal of investigative dermatology.

[33]  T. Takagi,et al.  Effect of a new potent H2-blocker, 3-]]]2-[(diaminomethylene)amino]-4-thiazolyl]methyl]-thio]-N2-sulfamoylpropionamidine (YM-11170) on gastric secretion induced by histamine and food in conscious dogs. , 1982, Archives internationales de pharmacodynamie et de therapie.

[34]  P. Weller,et al.  Eosinophil purification from peripheral blood. , 2014, Methods in molecular biology.

[35]  A. Strasser,et al.  Molecular and cellular analysis of human histamine receptor subtypes. , 2013, Trends in pharmacological sciences.

[36]  M. Rothenberg,et al.  The eosinophil. , 2006, Annual review of immunology.

[37]  M. Ball,et al.  Comparison of medium and long chain triglyceride metabolism in intensive care patients on parenteral nutrition , 2004, Intensive Care Medicine.

[38]  C. Reutelingsperger,et al.  Annexin V-affinity assay: a review on an apoptosis detection system based on phosphatidylserine exposure. , 1998, Cytometry.

[39]  N. Krug,et al.  Identification of eosinophils by cytometry , 1996 .

[40]  T. Takagi,et al.  Effect of a new potent H2-blocker, 3-[[[2-(diaminomethylene)amino]-4-thiazolyl]methyl]thio]-N2-sulfamoyl propionamidine (YM-11170), on gastric secretion, ulcer formation and weight of male accessory sex organs in rats. , 1982, Arzneimittel-Forschung.